FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / letter-ironclad-termination-commitment.docx
letter-ironclad-termination-commitment.docx · 1018-00008

Parties

HARKNESS LLP
Penterra Pharmaceuticals Corp
Secretary Penterra Pharmaceuticals Corp
M. Burgess
Financial Officer Penterra Pharmaceuticals Corp

Dates

October 1, 2024
June 7, 2024
June 10, 2024
December 10, 2024
September 30, 2024
September 27, 2024
September 8, 2024
July 22, 2024
October 15, 2024

Amounts

$500,000,000
$900,000,000
$400,000,000
$556,164

Obligations

Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Commitment Letter
The confidentiality obligations of both Penterra and the Commitment Parties, as set forth in Section 9 of the Commitment Letter, shall continue in full force and effect in accordance with their terms following the termination of the commitments
The indemnification obligations of the Borrower in favor of the Commitment Parties and their respective affiliates, directors, officers, employees, advisors, agents, and controlling persons, as set forth in Section 8 of the Commitment Letter, shall continue in full force and effect in accordance with their terms following the termination of the commitments
All fee payment obligations that accrued prior to the termination of the commitments, including commitment fees, ticking fees, and any other amounts payable under the Commitment Letter and the Fee Letter, shall remain due and payable in accordance with the terms thereof
The governing law provisions (Section 11, providing for application of the laws of the State of New York) and dispute resolution provisions (Section 12, providing for submission to the exclusive jurisdiction of the federal and state courts located in the Borough of Manhattan, City of New York) of the Commitment Letter shall survive the termination of the commitments